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Effective delivery of extraneous molecules into the cytoplasm of the target cells is 
important for several drug therapies. Previously, we showed effective in vivo transdermal 
delivery of naked siRNA into skin cells induced by faint electric treatment (ET) iontophoresis, 
and significant suppression of target mRNA levels (Kigasawa et al., Int. J. Pharm., 2010). This 
result indicates that electricity promoted the delivery of siRNA into cytoplasm. In the present 
study, we analyzed the intracellular delivery of naked anti-luciferase siRNA by faint ET, and 
found that the luciferase activity of cells expressing luciferase was reduced by in vitro ET like in 
vivo iontophoresis. Cellular uptake of fluorescent-label siRNA was increased by ET, while low 
temperature exposure, macropinocytosis inhibitor amiloride and caveolae-mediated endocytosis 
inhibitor filipin significantly prevented siRNA uptake. These results indicate that the cellular 
uptake mechanism involved endocytosis. In addition, voltage sensitive fluorescent dye DiBAC4 
(3) penetration was increased by ET, and the transient receptor potential channel inhibitor 
SKF96365 reduced siRNA uptake, suggesting that faint ET reduced membrane potentials by 
changing intracellular ion levels. Moreover, to analyze cytoplasmic delivery, we used in-stem 
molecular beacon (ISMB), which fluoresces upon binding to target mRNA in the cytoplasm. 
Surprisingly, cytoplasmic ISMB fluorescence appeared rapidly and homogeneously after ET, 
indicating that cytoplasmic delivery is markedly enhanced by ET. In conclusion, we 
demonstrated for the first time that faint ET can enhance cellular uptake and cytoplasmic 
delivery of extraneous molecules. 
 





Over the last decade, the delivery of extraneous hydrophilic molecules across the plasma 
membrane has been a subject of intense study. For effective therapies, small chemical molecules 
or large biological medicines, such as functional nucleic acids, must be delivered into the 
cytoplasm or nucleus of target cells. The lipophilic plasma membrane presents a dynamic barrier 
that restricts entry of extraneous hydrophilic or charged molecules into cells, while inefficient 
endosomal escape is another obstacle to effective delivery of macromolecular medicines [1, 2]. 
To overcome these cellular barriers, various strategies, including development of nanocarriers, 
cell penetrating peptides, and physical methods such as electroporation, have been studied [3, 4]. 
However, given the fundamental challenges of intracellular delivery, the versatile application of 
these systems remains unsatisfactory due to issues with delivery efficiency and toxicity of the 
carrier [5, 6]. Therefore, safer and more effective methods to deliver extraneous hydrophilic 
molecules into cells are needed. 
Iontophoresis has recently attracted the attention of researchers studying drug delivery 
systems. Iontophoresis is the promising non-invasive transdermal drug delivery technology [7-9]. 
Iontophoresis facilitates transdermal delivery of water soluble and ionized molecules by 
application of small electrical current (0.5 mA/cm2 or less) with electrodes on the skin surface. 
Thus, electric treatment of the skin provides the driving force for transdermal delivery of drug 
molecules. Previously, we demonstrated non-invasive in vivo transdermal delivery of naked 
siRNA induced by iontophoresis that significantly suppressed levels of target mRNA [10]. This 
result indicates that hydrophilic siRNA molecules could be delivered non-invasively into the 
cytoplasm of skin cells by faint electric treatment (ET) without the need for any modification of 
the siRNA to promote effective cellular association and endosomal escape. A mechanistic 
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analysis of the transdermal penetration of this macromolecule revealed that ET induced the 
dissociation of intracellular junctions via activation of cell signaling pathways mediated by 
protein kinase C (PKC) [11]. However the mechanism of cellular uptake and cytoplasmic 
delivery of siRNA and other hydrophilic molecules are still unclear. Here we explored whether 
faint ET could enhance cellular uptake and cytoplasmic delivery of extraneous hydrophilic 
molecules by affecting cellular physiology. 
We examined the effect of faint ET in the presence of siRNA targeting luciferase in cells 
stably expressing luciferase. Uptake mechanisms were analyzed by assessing the effect of low 
temperature and endocytosis inhibitors such as the clathrin-mediated endocytosis inhibitor 
hypertonic sucrose [12], the caveolae-mediated endocytosis inhibitor filipin [13], and the 
macropinocytosis inhibitor amiloride [14], on the cellular uptake of fluorescent labeled-siRNA. 
In addition, the effect of ET on membrane potential and the effect of a transient receptor 
potential (TRP) channel inhibitor on fluorescent labeled-siRNA uptake were also examined. We 
also analyzed the cytoplasmic delivery using a functional oligonucleotide in-stem molecular 
beacon (ISMB), which fluoresces upon specific binding with target mRNA in the cytoplasm [15]. 
The present study offers ET as an effective and safe technology for cytoplasmic delivery of 






2. Materials and Methods 
2.1 Materials 
In-stem molecular beacon (ISMB) against luciferase (5'-
C(Cy3:YD)TGG(YD)GTTGGCACCAGCAGCGCAC(Nitromethylred:Nm)(Nm)CCA(Nm)(Nm)G -
3': ISMB-Luc) and ISMB against GFP (5'-
G(YD)GTT(YD)GAAGAAGATGGTGCGCTCTC(Nm)(Nm)AAC(Nm)(Nm)C-3': ISMB-GFP) 
were synthesized by Tsukuba Oligo Service, Inc. (Tsukuba, Japan). Calcein, amiloride 
hydrochloride hydrate and filipin were purchased from Sigma-Aldrich, Inc. (St. Louis, MO, 
USA). SKF 96356 and sucrose were from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). 
DiBAC4(3)  was obtained from Dojindo Molecular Technologies, Inc. (Rockville, MD, USA). 
Lipofectamine 2000, anti-luciferase siRNA (21-mer, 5’-GCGCUGCUGGUGCCAACCCTT-3’, 
5’-GGGUUGGCACCAGCAGCGCTT-3’: anti-Luc) and anti-GFP siRNA (21-mer, 5’-
GCUGACCCUGAAGUUCAUCTT-3’, 5’-GAUGAACUUCAGGGUCAGCTT-3’: anti-GFP) were 
obtained from Invitrogen Life Technologies (Carlsbad, CA, U.S.A). Cell lysis buffer was 
purchased from Promega Corporation (Madison WI, USA). The mouse melanoma cell line B16-
F1 was obtained from Dainippon Sumitomo Pharma Biomedical Co, Ltd. (Osaka, Japan), and 
stable transformants of B16-F1 cells expressing luciferase (B16-F1-Luc) were established in our 
laboratory [16]. These cells were cultivated in DMEM supplemented with 10% FBS at 37 oC in 
5% CO2.  
 
2.2 Electric treatment of the cells 
For in vitro ET, cells were cultivated in 35 mm dishes. The number of cells used is 
mentioned in each section below. After 18 hr of cultivation, cells were washed with PBS, and 
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then 1 ml serum free DMEM containing 0.5 μg ISMB-Luc, 25 μM calcein, 100 pmol anti-Luc 
siRNA or anti-GFP siRNA was added to the cells. Ag-AgCl electrodes with 2.5 cm2 surface area 
(3M Health Care, Minneapolis, MN, USA) were placed into the dish, and cells were treated with 
a constant current of 0.34 mA/cm2 for 15 min. 
 
2.3 Transfection and measurement of luciferase activity 
B16-F1-Luc cells were cultivated at a density of 1x104 cells in 35 mm culture dishes. 
After 18 hr of incubation, cells were washed with PBS, and 1 ml serum free DMEM containing 
100 pmol anti-luc siRNA was added before the cells were treated with electricity as described 
above. After 3 hr of ET, 1 ml DMEM containing 10% FBS was added, and the cells were further 
incubated for 45 hr. After the incubation, the cells were lysed with Reporter Lysis Buffer 
(Promega) according to the manufacturer’s protocols. The luciferase assay substrate (Promega) 
was added to cell lysates, and chemiluminescence intensity was measured by a luminometer 
(Luminescensor-PSN, ATTO). The total protein concentration was measured with BCA protein 
assay kit (Thermo Scientific). 
 
2.4 Cytotoxicity assay of ET treated cells 
For determination of cytotoxicity, 4x105 B16-F1-Luc cells were cultivated in 35 mm 
culture dishes. After 18 hr of cultivation, cells were washed by PBS and added 1ml of serum free 
DMEM medium followed by ET for 15 min. Since the cytotoxicity by electricity-based delivery 
system, such as electroporation, had been observed at immediately after the treatment [17], we 
evaluated the cell viability at immediately after ET in this study. Immediate after ET, cells were 
collected from the dish by trypsin treatment, and taken 10 μl of cell suspension into a micro tube. 
An equal volume (10 μl) of 0.4% trypan blue solution (Wako Pure Chemical Industries, Ltd. 
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Osaka, Japan) was added to the cell suspension, and the mixture was incubated for 2 min. Then, 
the numbers of stained and non-stained cells were counted. The percentage of viability was 
calculated by the formula (100 x number of non-stained cells/ total number of cells). 
 
2.5 Treatment with low temperature or pharmacological inhibitors and measurement of 
fluorescence intensity 
For mechanistic studies, B16-F1 cells were seeded at a density of 1x105 cells in 35 mm 
culture dishes. After 18 h of cultivation, cells were washed with PBS. For low temperature 
experiments, 1 ml serum free DMEM containing 100 pmol rhodamine-labeled siRNA was added 
into the dish, and ET was then performed on ice. For pharmacological inhibitor experiments, 1 
ml serum free DMEM containing either 0.45 M sucrose, 1 mM amiloride, 0.5 μg filipin, or 25 
μM SKF96365 was added into the dish, and the dish was incubated for 15 min. After the 
incubation, rhodamine labeled siRNA (100 pmol) was added to the dish, and the cells were 
treated with electricity as described above. After the ET, the cells were incubated for 1 hr at 
37 °C. The cells were then lysed with reporter lysis buffer (Promega) according to the 
manufacturer’s protocols. Fluorescence intensity of the cell lysates was measured with a 
microplate reader Infinite 200 (Tecan Group Ltd., Männedorf, Switzerland )  at excitation and 
emission wavelengths of 546 nm and 576 nm, respectively. 
 
2.6 Membrane potential measurement 
To measure membrane potential, 5x104 cells were seeded in 35 mm culture dishes. After 
18 hr, cells were washed with PBS, and 2 ml DMEM containing 5 μM DiBAC4(3) dye was 
added before the cells were incubated for 30 min at room temperature. After incubation the cells 
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were treated with electricity for 15 min. ET was performed on ice in case of low temperature 
exposure. Then the cells were washed with PBS. The cells were lysed with reporter lysis buffer 
(Promega) according to the manufacturer’s protocols. Fluorescence intensity of the cell lysate 
was measured using the microplate reader. 
 
2.7 Confocal laser scanning microscopic observation of the cells after electric treatment 
For evaluation of intracellular delivery of ISMB-Luc, 5x104 cells were seeded on 0.002% 
poly-L-lysine coated 35 mm glass bottom dishes. After 18 hr, cells were washed with PBS and 
treated with ET (0.34 mA/cm2 for 15 min). After ET, the cells were incubated for 1 hr at 37 °C in 
5% CO2. After incubation, the cells were observed with a confocal laser scanning microscope 
A1R+ (Nikon Co. Ltd., Japan). For time-lapse imaging, observation was performed immediately 
after ET.   
 
2.8 Measurement of fluorescent intensity of the cells treated with ISMB 
For the comparison of ET based delivery with LFN based delivery of ISMB, B16-F1 
cells were cultivated at a density of 0.5x105 cells in 35 mm culture dishes. After 18 hr of 
cultivation, cells were washed with PBS. For ET, 800 μl of serum free DMEM containing 0.5 μg 
ISNB-Luc added into the dish. For LFN treatment, 800 μl of serum free DMEM containing 
ISMB-Luc/LFN lipoplex prepared with 0.5 μg ISNB-Luc and 1 μl LFN (according to the 
manufacturer guide line) was added into the dish. The cells were washed with PBS after ET 
(0.34 mA/cm2, 15 min) with ISMB-Luc or addition of LFN/ISMB-Luc lipoplex at various time 
points, and lysed cell with reporter lysis buffer (Promega) according to the manufacturer’s 
protocols. Fluorescence intensity of the cell lysates was measured by a microplate reader Infinite 
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200 (Tecan Group Ltd., Männedorf, Switzerland) at excitation and emission wavelengths of 525 
nm and 580 nm, respectively. 
 
2.9 Statistical analysis  
Statistical analysis was determined using one-way ANOVA followed by Turkey-Kramer HSD 











3.1 Effect of in vitro electric treatment on luciferase expression of cells with anti-luciferase 
siRNA 
To evaluate in vitro faint electric treatment (ET) on cellular uptake, the effect of ET with 
anti-luciferase (Luc) siRNA on luciferase activity of B16-F1-Luc cells stably expressing 
luciferase was examined. ET with anti-Luc siRNA significantly suppressed luciferase activity, 
which was similar to our previous report of iontophoresis of anti-interleukin 10 siRNA in vivo 
[10], although the RNAi effect was weaker than that for positive control cells incubated with 
Lipofectamine 2000/anti-Luc siRNA lipoplexes (Fig. 1). No suppression effect was observed for 
cells exposed to anti-GFP siRNA, indicating that the suppression effect was specific for anti-Luc 
siRNA. The cytotoxicity was evaluated immediately after ET. No cytotoxicity was recognized 
even after ET (Supplemental Fig. 1). This result indicates that ET did promote delivery of siRNA 
into the cytoplasm without the need for any modification of siRNA or other functional devices.  
 
Figure 1.  Effect of anti-Luc siRNA on luciferase activity in the presence of 
in vitro electric treatment (ET) 
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Luciferase activity of cells expressing luciferase was measured after 48 hr of 
ET (0.34 mA/cm2, for 15 min) in the presence of naked siRNA solution. 
Lipofectamine 2000/anti-Luc siRNA lipoplex was used as a positive control.  
LFN: lipofectamine 2000, ET: electric treatment. Data are expressed as 
mean±SD.  *p<0.05.  
 
3.2 Effect of low temperature and pharmacological inhibitors on ET-induced cellular uptake of 
siRNA 
 To study the mechanism of ET-mediated intracellular delivery, the effects of low 
temperature (0-4 °C) and endocytosis inhibitors on cellular uptake of rhodamone-labeled siRNA 
were examined. The fluorescence intensity of cellular lysates was significantly increased by ET 
at room temperature (Fig. 2), indicating that cellular uptake of rhodamone-labeled siRNA was  
Figure 2.  Effects of low temperature and endocytosis inhibitors on cellular 
uptake of rhodamine-labeled siRNA 
For low temperature treatment, ET of cells was performed on ice. To 
examine the effect of inhibitors, cells were pre-treated for 15 min with 
inhibitors prior to the exposure to electricity (0.34 mA/cm2, for 15 min) in 
the presence of siRNA solution. After 1 hr of ET, the cells were lysed, and the 
fluorescence intensity of the lysate was measured. Data are expressed as 




























































enhanced by ET. Low temperature (0-4 °C) treatment is commonly used to nonspecifically 
inhibit energy-dependent cellular uptake [18]. Thus, we assessed the effect of low temperature 
on ET-mediated cellular uptake by treating cells with electricity in the presence of rhodamone-
labeled siRNA on ice. As a result, low temperature treatment significantly reduced the 
fluorescence intensity, which implies that cellular uptake of siRNA was inhibited (Fig. 2). This 
result suggests that ET activated biological processes involving energy-dependent pathways.  
 To specify the cellular uptake pathway induced by ET, effects of the macropinocytosis 
inhibitor amiloride, the caveolae-mediated endocytosis inhibitor filipin, and the clathrin-
mediated endocytosis inhibitor hypertonic sucrose on fluorescent-labeled siRNA uptake were 
examined. Clathrin-mediated endocytosis inhibitor hypertonic sucrose slightly inhibited siRNA 
uptake, although the inhibition was not statistical significant. Furthermore, macropinocytosis 
inhibitor amiloride and caveolae-mediated endocytosis inhibitor filipin showed significant 
reduction of fluorescent labeled-siRNA uptake. 
 
3.3 Evaluation of the effect of ET on membrane potential 
Since ET was previously suggested to affect intracellular ion balance [11], ET may also 
promote altered membrane potentials that could enhance the cellular uptake of extraneous 
materials. Thus, to evaluate the effect of ET on membrane potential, cells were treated with 
electricity in the presence of the voltage sensitive fluorescent dye DiBAC4(3) [19, 20]. After ET, 
the fluorescence intensity of cells treated with ET was higher than the control cells (Fig. 3), 
indicating that ET decreased the membrane potential of the cells through a process that may 
involve the influx of cations such as Ca2+. In quantitative measurements of fluorescence intensity, 
intracellular amounts of DiBAC4(3) increased by 13 % (Fig. 3). In order to confirm the 
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possibility of physical penetration of DiBAC4(3), the effect of low temperature on cellular 
staining with DiBAC4(3) dye was examined. As a result, the fluorescent intensity depending on 
DiBAC4(3) dye was almost the same as that of control cells (Fig. 3), indicating that the 
membrane potential was not changed at low temperature even after ET. This result suggested 
 
Figure 3. Evaluation of DiBAC4(3) cellular penetration in the presence of 
faint ET 
Cells were incubated for 30 min with DiBAC4(3) followed by ET (0.34 
mA/cm2) for 15 min. For low temperature exposure, ET was performed on ice. 
After ET, cells were lysed and the fluorescence intensity of the lysate was 
measured. Data are expressed as mean ± SD.  *p<0.05. 
 
that ET-induced activation of cation channels, such as transient receptor potential (TRP) 
channels, could have resulted in the observed alterations in membrane potential. Thus, to analyze 
the role of TRP channels in ET-mediated cellular uptake, the effect of the TRP channel blocker 
SKF96365 [21] on the fluorescence intensity of cells treated with ET in the presence of 
fluorescent-labeled siRNA was examined. ET-mediated cellular uptake of siRNA was 
significantly reduced by SKF96365 (Fig. 4). Nonetheless, this result suggests that activation of 




















































Figure 4.  Effect of TRP channel inhibitor SKF96365 on cellular uptake of 
rhodamine-labeled siRNA 
Cells were pre-treated for 15 min with SKF96365 before being treated with 
electricity (0.34 mA/cm2, for 15 min) in the presence of rhodamine-labeled 
siRNA solution. After ET, cells were lysed and the fluorescence intensity of 
the lysate was measured. Data are expressed as mean ± SD.  *p<0.05. 
 
3.4 Evaluation of ET-mediated cytoplasmic delivery processes 
As mentioned above, ET could induce cytoplasmic delivery during the uptake of 
extraneous materials. Thus, the materials must overcome membranous barriers, such as plasma 
membrane and endosomal membrane, after ET-mediated cellular uptake. To analyze cytoplasmic 
delivery  processes after ET-mediated cellular uptake, cytoplasmic delivery of in-stem molecular 
beacon (ISMB), which can show potent fluorescence signals upon association with target mRNA 
(here, luciferase, ISMB-Luc), into B16F1-Luc cells was evaluated by confocal laser scanning 
microscopy. One hour after ET, all cells showed potent red fluorescence signals, although no 















































(Fig. 5). On the other hand, no fluorescence signal was seen in the cells after 1 hr ET in the 
presence of ISMB against GFP (ISMB-GFP). These results indicated that ISMB-Luc efficiently  
Figure 5.  Cytoplasmic delivery of in-stem molecular beacon (ISMB) 
induced by faint ET 
Cells were treated with faint electricity (0.34 mA/cm2, 15 min) in the 
presence of ISMB solution. After 1 hr, the cells were observed with a 
confocal laser scanning microscope. Left and middle panel images are cells 
incubated in medium containing ISMB against luciferase mRNA (ISMB-
Luc) with or without ET. The image in the right panel shows cells incubated 
in medium with ISMB against GFP mRNA (ISMB-GFP) in the presence of 
ET. The scale bars indicate 50 μm.  
 
reach to the cytoplasm after ET-mediated cellular uptake and specifically bound with 
target luciferase mRNA in the cytoplasm.  
To evaluate cytoplasmic delivery processes, we next performed time-lapse imaging of 
cells immediately after ET. Surprisingly, ISMB fluorescence signals appeared in the cytoplasm 
immediately after ET, and the fluorescence intensity rapidly increased for 15 min (Supplemental 
Fig. 2). In contrast, no fluorescence signals were observed in cells without ET even after 15 min. 
This result confirmed that endosomal escape of extraneous materials after ET-mediated cellular 
uptake was very rapid and effective. Furthermore, to evaluate the speed of cytoplasmic delivery 
of ET method, fluorescent intensities of the cells treated by electricity in the presence of ISMB-
Luc at various time points were compared with the cells treated by LFN/ISMB-Luc lipoplex. As 
a result, the significant fluorescent intensity was observed in the cells of ET method even at 15 
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min. The fluorescent intensity of ET was over 4 fold higher than that of LFN at 30 min. 
(Supplemental Fig. 3) Furthermore the cells after ET with ISMB-Luc or transfection of 
LFN/ISMB-Luc were observed by confocal laser scanning microscopy. As a result, red 
fluorescent signals were observed in all cells treated with electricity, although heterogeneous 
distribution of red fluorescent signals recognized in the cells after transfection of LFN. 







Cytoplasmic delivery of hydrophilic molecular medicines, such as functional nucleic 
acids, is difficult to achieve due to membranous barriers, including the plasma membrane and 
endosomal membrane [22]. Thus, ineffective delivery is an important concern that must be 
addressed in order to improve drug delivery methods. Recently, we found that in vivo faint 
electric treatment (ET) iontophoresis can deliver functional siRNA into the cytoplasm of skin 
cells [10]. Based on this finding, we hypothesized that faint ET could enhance cellular uptake 
and cytoplasmic delivery of extraneous hydrophilic molecules by affecting cellular physiology.  
In this study, we first confirmed that the significant RNAi effect by faint ET in vitro (Fig. 
1). Although the suppression effect was lower than that of Lipofectamine 2000/siRNA lipoplexes, 
this result indicates that siRNA was delivered into the cytoplasm by electricity and without any 
modification of siRNA to promote effective cellular association and endosomal escape. The 
reduced effect of ET in facilitating RNAi may be due to the amount of siRNA that reached the 
cytoplasm. Although lipoplexes can deliver much higher amounts of siRNA as condensed 
particles into cells, ET induced cellular uptake of a homogenous siRNA solution rather than 
concentrated bodies. Thus, delivery efficiency could be improved with additional studies. 
We next found that the cellular uptake of siRNA was enhanced by ET in the presence of 
fluorescent-labeled siRNA (Fig. 2). The ET-enhanced cellular uptake of labeled siRNA was 
significantly reduced by low temperature treatment (Fig. 2), indicating that ET-mediated cellular 
uptake processes likely involved energy dependent pathways. In order to further characterize the 
uptake process, we used a wide range of endocytosis inhibitors, including the clathrin-mediated 
endocytosis inhibitor hypertonic sucrose [12], the caveolae-mediated endocytosis inhibitor filipin 
[13] and the macropinocytosis inhibitor amiloride [14]. Partial inhibitory effect was induced by 
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hypertonic treatment with sucrose, while significant inhibitory effects were obtained by 
amiloride and filipin treatment (Fig. 2). It was suggested that endocytosis, such as 
macropinocytosis or caveolae-mediated endocytosis, would be involved in ET mediated uptake 
of siRNA.  
The voltage clamping membrane potential was previously shown to vary between -25 
mV and -90 mV for BICR/MIR-k cells, and the fluorescence response of the voltage sensitive 
dye DiBAC4(3) was found to be about 1% per mV [20]. In the present study, we observed that 
ET significantly increased the fluorescence intensity of DiBAC4(3) by 13 % over that of control 
cells (Fig. 3). Thus, this result indicated that ET induced a membrane potential decrease in 
approximately 13 mV. The fluorescent intensity did not increase at low temperature. It was 
suggested that membrane potential change by ET would be due to biological mechanism, not 
physical factors such as membrane leak. Moreover, activation of non-specific cation channels- 
known as TRP channels- is known to alter cellular membrane potentials [23]. Here, cellular 
uptake of fluorescent-labeled siRNA was significantly reduced by the TRP channel blocker 
SKF96365 (Fig. 4), indicating that cationic channels would be involved in ET-mediated cellular 
uptake processes. Together these findings implicate membrane potential changes via activation 
of cationic channels, such as TRP channels, in contributing to ET-mediated cellular uptake of 
extraneous materials. Previously we reported that Ca2+ influx-mediated PKC activation could be 
responsible for iontophoresis-induced opening of intercellular junctions in the skin [11]. 
Therefore, combining the previous in vivo findings and the in vitro findings of the present study, 
faint ET appears to regulate physiology of tissues and cells by promoting cationic ion influx. 
Breakthrough of membranous barriers is also an important step for cargo molecules to be 
delivered to the cytoplasm following cellular uptake [24]. We monitored the cytoplasmic 
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delivery process using ISMB-Luc. The ISMB probe is a hairpin-shaped oligonucleotide that 
contains fluorophores and quenchers. In the absence of target mRNA, the fluorescence emission 
of the probe is quenched by interactions between the fluorophores and quenchers. In the presence 
of target mRNA, the ISMB hairpin structure opens, thus releasing the fluorophore to result in 
fluorescence emission [15]. Interestingly, we observed that all cells showed strong red 
fluorescence after 1 hr of ET with ISMB-Luc (Fig. 5), which supports that ET induced efficient 
cytoplasmic delivery of ISMB-Luc, and that ISMB-Luc could associate with luciferase mRNA in 
the cytoplasm. Surprisingly, fluorescence signals appeared immediately after ET, and the 
intensity of the signal increased rapidly for a short period (Supplemental Fig. 2), indicating that 
cytoplasmic delivery was indeed enhanced by faint electric treatment.  
Although the knockdown effect by siRNA treated with ET was weaker than that with 
LFN, the ET method homogenously and very rapidly delivered functional nucleotide ISMB into 
cytoplasm of all cells (Fig. 5 and Supplemental Figs. 2 and 4). Even 15 min after ET, red 
fluorescent signals were observed in cytoplasm (Supplemental Figs. 2 and 3), indicating that 
ISMB rapidly reached and bind with a target mRNA. Furthermore, from the results of 
comparison of ISMB cytoplasmic delivery between ET method and LFN, it was suggested that 
ISMB was delivered rapidly and homogeneously into cytoplasm by ET method, and the delivery 
speed into cytoplasm of ET method was faster than LFN (Supplemental Figs. 3 and 4). Thus, the 
rapid and homogenous delivery of functional nucleotides into cytoplasm is the advantage of ET, 
although the delivery efficiency should be improved in the future. Since functional nucleic acid 
medicines are easily degraded by degradation enzymes at the extracellular environment and 
inside of endosome, long stay in such situation reduce activity of the medicines. Thus, rapid 
cellular uptake and cytosolic delivery would be useful for effective therapy due to avoiding the 
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decrease in activity of nucleic acids. Furthermore, for effective therapy, medicines should be 
delivered into all target cells. Since heterogeneous delivery is the cause of inefficient RNAi 
effect [25], siRNA should be delivered into all cells for effective regulation of target genes. Thus, 
homogenous delivery would be useful for effective therapy. As mentioned above, the reason for 
lower RNAi effect by ET method than that of LFA would be due to less cellular uptake amount 
of siRNA. Thus, the cooperative effect by combination of ET method with cationic non-viral 
delivery system is expected to improve delivery efficiency of ET method. The accumulation of 
cargo on the cell surface would increase by cationic carriers, and cellular uptake and cytosolic 
delivery would be enhanced by ET method. Thus, we expected that ET method would be 
improved by combination with other delivery methods, such as cationic non-viral delivery 
systems. To our knowledge, this study represents the first report of rapid and effective 
cytoplasmic delivery of extraneous hydrophilic materials induced by faint ET, although the 
underlying mechanism for this rapid delivery into the cytoplasm await further investigation. 
 
5. Conclusion 
In the present study we found that faint electric treatment can enhance cellular uptake and 
rapid cytosolic delivery by inducing energy-dependent pathways along with the activation of 
cationic channels. Thus, faint electric treatment could be useful for effective and safe delivery of 
extraneous hydrophilic molecules, such as siRNA, miRNA and decoy-oligo DNA, into the 
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Figure 1.  Effect of anti-Luc siRNA on luciferase activity in the presence of in vitro electric 
treatment (ET) 
Luciferase activity of cells expressing luciferase was measured after 48 hr of ET (0.34 mA/cm2, 
for 15 min) in the presence of naked siRNA solution. Lipofectamine 2000/anti-Luc siRNA 
lipoplex was used as a positive control.  LFN: lipofectamine 2000, ET: electric treatment. Data 
are expressed as mean±SD.  *p<0.05.  
 
Figure 2.  Effects of low temperature and endocytosis inhibitors on cellular uptake of 
rhodamine-labeled siRNA 
For low temperature treatment, ET of cells was performed on ice. To examine the effect of 
inhibitors, cells were pre-treated for 15 min with inhibitors prior to the exposure to electricity 
(0.34 mA/cm2, for 15 min) in the presence of siRNA solution. After 1 hr of ET, the cells were 
lysed, and the fluorescence intensity of the lysate was measured. Data are expressed as mean±SD.  
*p<0.05. 
 
Figure 3.  Evaluation of DiBAC4(3) cellular penetration in the presence of faint ET 
Cells were incubated for 30 min with DiBAC4(3) followed by ET (0.34 mA/ cm2) for 15 min. 
For low temperature exposure, ET was performed on ice. After ET, cells were lysed and the 
fluorescence intensity of the lysate was measured. Data are expressed as mean ± SD.  *p<0.05. 
 




Cells were pre-treated for 15 min with SKF96365 before being treated with electricity (0.34 
mA/cm2, for 15 min) in the presence of rhodamine-labeled siRNA solution. After ET, cells were 
lysed and the fluorescence intensity of the lysate was measured. Data are expressed as mean ± 
SD.  *p<0.05. 
 
Figure 5.  Cytoplasmic delivery of in-stem molecular beacon (ISMB) induced by faint ET 
Cells were treated with faint electricity (0.34 mA/cm2, 15 min) in the presence of ISMB solution. 
After 1 hr, the cells were observed with a confocal laser scanning microscope. Left and middle 
panel images are cells incubated in medium containing ISMB against luciferase mRNA (ISMB-
Luc) with or without ET. The image in the right panel shows cells incubated in medium with 
ISMB against GFP mRNA (ISMB-GFP) in the presence of ET. The scale bars indicate 50 μm.  
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